23 Jul, 2026
According to Straits Research, the global AI-enabled X-ray imaging solutions market valued at $486.2 million in 2025, is projected to grow from $585.5 million in 2026 to $2,619 million by 2034 at a CAGR of 20.6% during the forecast period 2026–2034.
AI-enabled X-ray imaging solutions are a suite of medical diagnostics that allows radiologists to evaluate and analyze complex images of various organs and their conditions with greater speed and accuracy. To evaluate data, conduct risk assessments, and conduct predictive analyses, they use a variety of hardware and software solutions that employ computational algorithms. These facilities reduce the need for human specializations, enable information-driven decision-making, enhance image quality, reduce radiation exposure, and assist clinicians in delivering superior clinical care. In general and specialty radiology, AI-enabled X-ray imaging solutions are extensively utilized to clarify patient anomalies and provide superior treatment options thoroughly.
There are difficulties in the education, training, deployment, and performance of health workforces in nations with varying levels of socioeconomic development. According to the World Health Organization, there will be a worldwide shortage of 12.9 million healthcare employees by 2035. In addition to developing countries, developed nations such as the U.S. and the U.K. are also experiencing an uneven distribution of healthcare professionals.
In addition, developing economies such as sub-Saharan Africa and sections of Asia have inadequate healthcare systems, most likely due to the migration of their health professionals. As a result, healthcare providers around the globe are increasingly implementing AI-enabled technologies that mimic cognitive behaviors to combat the growing shortage of skilled healthcare workers. In turn, this is driving the expansion of the market as a whole.
Numerous industry stakeholders have recognized the benefits of employing AI in medical imaging. Intel Corporation, IBM Corporation, and Microsoft Corporation are collaborating with several minor and large players in the information technology industry (for the parent market). For instance, IBM Watson Health and Guerbet signed a joint development agreement in July 2018 to develop an AI-enabled software solution to improve the detection and treatment of liver cancer using CT and MRI imaging.
In addition, leading providers of medical imaging modalities, such as GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips N.V., are also forming strategic alliances with developers of AI-enabled software solutions. For instance, Koninklijke Philips N.V. concluded the acquisition of Carestream Health's cloud-based enterprise imaging platform in March 2019, which is expected to expand its radiology informatics portfolio for imaging data management, workflow enhancement, and advanced visualization and analysis.
The AI-enabled X-ray imaging solutions market in North America had a revenue share of 42.60% in 2025, driven by growing use of X-ray imaging in population screening programs, expansion of outpatient imaging centers and decentralized diagnostics, and strong clinical focus on rapid triage in emergency departments. The region widely uses X-ray imaging in screening and early detection programs such as chest imaging for lung disease and mammography-based breast cancer detection. AI tools that assist with abnormality detection and image interpretation help improve diagnostic consistency across large screening populations. The region has seen rapid growth in outpatient imaging centers and ambulatory diagnostic facilities that perform high volumes of routine radiographic exams. These facilities often operate with lean clinical teams, creating demand for AI-enabled X-ray systems. Emergency departments in the region handle a high volume of trauma, respiratory illness, and orthopedic injury cases where AI-based X-ray solutions are used to automatically flag urgent conditions enable faster triage and clinical decision-making.
The market in Asia Pacific is anticipated to register a CAGR of 22.7% during the forecast period. The market is expanding rapidly, driven by China’s accelerated hospital AI adoption, with annual installations rising over 30%, and India’s nationwide AI-based tuberculosis and multi-disease screening programs, which address radiologist shortages and expand early diagnostic access. These region-specific initiatives significantly boost market penetration and healthcare efficiency.
Europe's AI-enabled X-ray imaging solutions market is supported by the EU’s strict AI and medical device regulations, including MDR and GDPR, which promote safe, ethical, and interoperable use across member states. Additionally, national AI strategies in Germany, France, and the Netherlands support clinical trials and federated imaging analytics, improving diagnostic precision and encouraging wider adoption of AI-driven healthcare solutions.
sales@straitsresearch.com